XML 88 R76.htm IDEA: XBRL DOCUMENT v3.24.3

Related Party Transactions (Details) - Schedule of Fair Value of the Options Granted to Each Individual and the Related Expense - USD ($)		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023
Related Party Transaction [Line Items]
Individual and related expense		$ (1,819)	$ 145,516
Fair value of stock options granted		1,049,898
Braeden Lichti, Chairman [Member]
Related Party Transaction [Line Items]
Individual and related expense	[1]	1,894	5,398
Fair value of stock options granted	[1]	50,995
Graydon Bensler, CEO, CFO and Director [Member]
Related Party Transaction [Line Items]
Individual and related expense		1,897	5,398
Fair value of stock options granted		50,995
Jordan Plews, Director and CEO of Skincare and BioSciences [Member]
Related Party Transaction [Line Items]
Individual and related expense		1,897	5,398
Fair value of stock options granted		50,995
Tim Sayed, Former Chief Medical Officer and Former Director [Member]
Related Party Transaction [Line Items]
Individual and related expense	[1]	(4,291)	5,398
Fair value of stock options granted	[1]	50,995
Jeffrey Parry, Director [Member]
Related Party Transaction [Line Items]
Individual and related expense		18,564	21,177
Fair value of stock options granted		107,669
Crystal Muilenburg, Former Director [Member]
Related Party Transaction [Line Items]
Individual and related expense	[1]	(41,668)	46,725
Fair value of stock options granted	[1]	210,245
Julie Daley, Director [Member]
Related Party Transaction [Line Items]
Individual and related expense		69,111	56,022
Fair value of stock options granted		210,245
George Kovalyov, Director [Member]
Related Party Transaction [Line Items]
Individual and related expense		18,144
Fair value of stock options granted		52,845
Brenda Buechler, Former Chief Marketing Officer [Member]
Related Party Transaction [Line Items]
Individual and related expense	[1]	(36,918)
Fair value of stock options granted	[1]	143,671
Christoph Kraneiss, Former Chief Commercial Officer [Member]
Related Party Transaction [Line Items]
Individual and related expense	[1]	(30,449)
Fair value of stock options granted	[1]	$ 121,243
[1] 354,990 options of related parties were forfeited in the nine months ended September 30, 2024.

X

- Definition

Represent the amount of grant date fair value of stock options.

+ References

No definition available.

+ Details

Name:	elab_FairValueOfStockOptionsGranted
Namespace Prefix:	elab_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of transactions with related party during the financial reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-3

+ Details

Name:	us-gaap_RelatedPartyTransactionAmountsOfTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_BraedenLichtiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_GraydonBenslerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_JordanRPlewsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_TimSayedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_JeffreyParryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_CrystalMuilenburgMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_JulieDaleyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_GeorgeKovalyovDirectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_BrendaBuechlerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=elab_ChristophKraneissMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: